Keywords: blow, akzo, nobel, fda, asks, data, ariza

Blow for Akzo Nobel as FDA asks for more data on Ariza antidepressant

Article | 22 April 2002

Print This

Dutch chemical and pharmaceutical group Akzo Nobel has said that it willbe unable to launch its new antidepressant drug Ariza ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in